# Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee Osteoarthritis

> **NCT07646483** · NA · NOT_YET_RECRUITING · sponsor: **PharmaResearch Co.,Ltd** · enrollment: 180 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DEVICE:** Conjuran
- **DRUG:** Hyruan

## Key facts

- **NCT ID:** NCT07646483
- **Lead sponsor:** PharmaResearch Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2027-09
- **Final completion:** 2028-07
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07646483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07646483, "Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee Osteoarthritis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07646483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*